NCITA is collaborating with clinical researchers across the UK to provide NCITA Repository, Imaging Clinical Trials Unit and QA/QC Unit support for multicentre clinical imaging biomarker studies.

NCITA infrastructure support is available to external partners from both academia and industry, provided the clinical research proposal meets the NCITA study eligibility criteria.

For more information on the study adoption application process, please contact us at or using our contact form.

External Studies Adopted by the NCITA Infrastructure

Plasma Analysis for Response Assessment and to Direct the manaGement of Metastatic prostate cancer – imaging sub-study

NCITA CTU, QA/QC Unit, Repository Unit

Lymphatic Mapping Of Oropharyngeal Cancer

NCITA Imaging Clinical Trials Unit, Repository Unit


Head and Neck Early Relapse Detection Study

NCITA Imaging Clinical Trials Unit, Repository Unit


Predicting response to neoadjuvant chemotherapy and neoadjuvant radiotherapy in patients with oesophageal cancer at baseline using PET-CT and contrast enhanced radiomics

NCITA Imaging Clinical Trials Unit, QA/QC Unit, Repository Unit